L & L biopharma | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Director New Product Planning

Morphosys

Click here for more information

Data insights

24 September 2025

Joyo starts its first pivotal trial

While InxMed, Takara and L&L have phase 3 plans in lung cancer and beyond.

Subscribe to L & L biopharma